Insulet PODD Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's long-term debt?
- Insulet (PODD) reported long-term debt of $948.1M in Q1 2026.
- How has Insulet's long-term debt changed year-over-year?
- Insulet's long-term debt decreased by 44.1% year-over-year, from $1.7B to $948.1M.
- What is the long-term trend for Insulet's long-term debt?
- Over 5 years (2020 to 2025), Insulet's long-term debt has grown at a -1.9% compound annual growth rate (CAGR), from $1.04B to $949.2M.
- What does long-term debt mean?
- Total debt that is not due for repayment within the next year.
- How do you interpret long-term debt?
- High levels indicate significant financial leverage, which can amplify returns but also increase financial risk.
- How does long-term debt compare across companies?
- Often analyzed via debt-to-equity or net debt-to-EBITDA ratios compared to other medical device manufacturers.